Diagnostic and treatment burden of dystonia in Turkey: a patient journey map
Objective: To assess the burden of access to diagnosis and botulinum neurotoxin (BoNT) treatment in Turkish patients with dystonia and hemifacial spasm (PwD/HFS). Background: Diagnostic…Conventional anti-epileptic drugs used in North Sea Progressive Myoclonus Epilepsy revisited in a Drosophila model
Objective: To determine the effect of conventional anti-epileptic drugs in a North Sea Progressive Myoclonus Epilepsy (NS-PME) Drosophila model. Background: In 2011, Corbett et al.…Autoimmune Chorea. Therapy with Monoclonal Antibodies: Experimental and Clinical Approach
Objective: Autoimmune chorea (AICh) resulting from the appearance of paraneoplastic antibodies in response to development of malignant tumors of various localization. Sydenham's rheumatic chorea, described…Effects of NE3107 anti-inflammatory treatment on motor activity and neurodegenerative features of Parkinson’s disease in a marmoset monkey model
Objective: To demonstrate the effects of an oral, anti-inflammatory agent, NE3107, on motor activity, levodopa-induced dyskinesia (LID) induction, and neuron survival in a marmoset model…REM sleep behaviour disorder in Parkinson’s disease: prevalence and correlation with other sleep parameters
Objective: to assess the prevalence of probable rapid eye movement (REM) sleep behavior disorder (RBD) in Parkinson’s disease (PD) patients and its correlation with other…Parkinson’s disease management in the community
Objective: To explore perceptions of people with Parkinson's disease and family carers about the use and impact of health and social care services, community and…The East London Parkinson Disease Project – preliminary results from a diverse population
Objective: The East London Parkinson Disease (ELPD) project is a platform study to understand the manifestations and determinants of PD in a diverse population. Background:…Motor evaluation of Parkinson disease and Vascular parkinsonism using the TUG encephalog application
Objective: We aimed to compare gait and parkinsonian features between PD patients, VP patients and PD patients with Vascular component (PDVC) using a smartphone-based motion…Design of a time-to-event study in GBA Parkinson’s Disease patients: Efficacy and safety of BIA 28-6156, an allosteric activator of beta-glucocerobridase (GCase)
Objective: To assess the efficacy of BIA 28-6156 in delaying clinically meaningful motor progression in PD patients who have a PD-risk associated variant in the…Positive and negative myoclonus monitoring using ambulatory surface EMG and 3D accelerometry
Objective: An objective method is presented for monitoring of positive and negative myoclonus using wearable surface EMG and 3D accelerometry in clinical and home settings.…
- « Previous Page
- 1
- …
- 262
- 263
- 264
- 265
- 266
- …
- 1554
- Next Page »